Publication | Closed Access

Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1? and interleukin-6 release from lymphocytes of Alzheimer's disease patients

Alzheimer's DiseaseAcetylcholinesterase Inhibitors EffectsMedicineDementiaPharmacologyInterleukin-6 ReleaseNeuropharmacologyNeurochemical BiomarkersBrain-immune InteractionNeurologyDisease PatientsAging-associated DiseaseNeuroimmunologyTreatmentNeuroinflammation